Advanced Institute Of Liver And Biliary Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.38 Cr
- Revenue Growth 60.01%
- Profit Growth 79.48%
- Ebitda 37.42%
- Net Worth 21.34%
- Total Assets 11.94%
About Advanced Institute Of Liver And Biliary Sciences
Advanced Institute Of Liver And Biliary Sciences Private Limited (AIOLABSPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2016 (Eight years and four months 16 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹19.38 Cr.
Vivek Vij and Sonia Vij serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2016PTC307038
- Company No.
307038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2016
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Advanced Institute Of Liver And Biliary Sciences?
Financial Performance of Advanced Institute Of Liver And Biliary Sciences.
Advanced Institute Of Liver And Biliary Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.01% increase. The company also saw a substantial improvement in profitability, with a 79.48% increase in profit. The company's net worth Soared by an impressive increase of 21.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Institute Of Liver And Biliary Sciences?
In 2021, Advanced Institute Of Liver And Biliary Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹193.84 M
₹0
Charges Breakdown by Lending Institutions
- Others : 19.00 Cr
- Hdfc Bank Limited : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2022 | Hdfc Bank Limited | ₹3.84 M | Open |
| 29 Mar 2018 | Others | ₹19.00 Cr | Open |
How Many Employees Work at Advanced Institute Of Liver And Biliary Sciences?
Unlock and access historical data on people associated with Advanced Institute Of Liver And Biliary Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Institute Of Liver And Biliary Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Institute Of Liver And Biliary Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.